H.R. 1497

119 HR 1497 IH: NIH Reform Act
 U.S. House of Representatives
 2025-02-21
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 1497  IN THE HOUSE OF REPRESENTATIVES   February 21, 2025   Mr. Roy  (for himself,  Mr. Griffith ,  Ms. Hageman ,  Mr. Crane , and  Mr. Brecheen ) introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To replace the National Institute of Allergy and Infectious Diseases with 3 separate national research institutes.
1.
Short title
This Act may be cited as the   NIH Reform Act  .
2.
Division of National Institute of Allergy and Infectious Diseases
(a)
Organization of national research institutes
Section 401 of the Public Health Service Act ( 42 U.S.C. 281 ) is amended—
(1)
in subsection (b)—
(A)
in paragraph (6), by striking  Allergy and Infectious Diseases  and inserting  Allergic Diseases ;
(B)
by redesignating paragraph (25) as paragraph (27); and
(C)
by inserting after paragraph (24) the following:
(25)
The National Institute of Infectious Diseases.
(26)
The National Institute of Immunologic Diseases.
 ; and
(2)
in subsection (d)(1), by striking  27  and inserting  29 .
(b)
Appointment of directors
(1)
In general
Section 405(a)(1) of the Public Health Service Act ( 42 U.S.C. 284(a)(1) ) is amended—
(A)
by inserting  , the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases  after  National Cancer Institute ; and
(B)
by inserting  by and with the advice and consent of the Senate,  after  the President, .
(2)
Terms
Section 405(a) of the Public Health Service Act ( 42 U.S.C. 284(a) ) is amended by adding at the end the following:
(4)
Certain appointments by the President
The appointments by the President of the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases shall be for terms of 5 years. Each such Director may be reappointed for not more than 1 additional term, in accordance paragraph (1).
 .
(3)
Transition
Effective on the date of enactment of this Act, the position of Director of the National Institute of Allergy and Infectious Diseases is terminated, and the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases shall be overseen by the Director of the National Institutes of Health until such time as the directors of each such national institutes is appointed pursuant to section 405(a)(1) of the Public Health Service Act ( 42 U.S.C. 284(a)(1) ), as amended by paragraph (1).
(c)
Duties of the National Institutes
(1)
National Institute of Allergic Diseases
Subpart 6 of part C of title IV of the Public Health Service Act ( 42 U.S.C. 285f et seq. ) is amended—
(A)
in the subpart heading, by striking
Allergy and infectious diseases   and inserting
Allergic Diseases  ; and
(B)
in section 446—
(i)
by striking  Allergy and Infectious Diseases  and inserting  Allergic Diseases ; and
(ii)
by striking  allergic and immunologic diseases and disorders and infectious diseases, including tropical diseases  and inserting  allergic diseases and disorders .
(2)
National Institute of Infectious Diseases
(A)
In general
Part C of title IV of the Public Health Service Act ( 42 U.S.C. 285 et seq. ) is amended by adding at the end the following:
21
National Institute of Infectious Diseases
464z–10.
Purpose of the Institute
The general purpose of the National Institute of Infectious Diseases is the conduct and support of research, training, health information dissemination, and other programs with respect to infectious diseases, including tropical diseases.
  .
(B)
Transfer of authorities
Sections 447A and 447B of the Public Health Service Act ( 42 U.S.C. 285f–2 ; 285f–3) are—
(i)
redesignated as sections 464z–11 and 464–12, respectively; and
(ii)
transferred to appear after section 464z–10 of such Act, as added by subparagraph (A).
(C)
Orderly transition
The Director of the National Institutes of Health shall take such steps as are necessary to provide for the orderly transition to the authority of the National Institute of Infectious Diseases established under section 464z–10 of the Public Health Service Act, as added by subparagraph (A), from any authority related to infectious diseases of the National Institute of Allergy and Infectious Diseases, as in effect on the day before the date of enactment of this Act.
(3)
National Institute of Immunologic Diseases
(A)
In general
Part C of title IV of the Public Health Service Act ( 42 U.S.C. 285 et seq. ), as amended by paragraph (2), is further amended by adding at the end the following:
22
National Institute of Immunologic Diseases
464z–15.
Purpose of the Institute
The general purpose of the National Institute of Immunologic Diseases is the conduct and support of research, training, health information dissemination, and other programs with respect to immunologic diseases and disorders.
  .
(B)
Transfer of authorities
Sections 447 and 447C of the Public Health Service Act ( 42 U.S.C. 285f–1 ; 285f–4) are—
(i)
redesignated as sections 464z–16 and 464z–17, respectively; and
(ii)
transferred to appear after section 464z–15 of such Act, as added by subparagraph (A).
(C)
Orderly transition
The Director of the National Institutes of Health shall take such steps as are necessary to provide for the orderly transition to the authority of the National Institute of Immunologic Diseases established under section 464z–15 of the Public Health Service Act, as added by subparagraph (A), from any authority related to immunologic diseases and disorders of the National Institute of Allergy and Infectious Diseases, as in effect on the day before the date of enactment of this Act.
(d)
Conforming amendments
(1)
Section 404B of the Public Health Service Act ( 42 U.S.C. 283d ) is amended by striking  National Institute for Allergy and Infectious Diseases  and inserting  National Institute of Infectious Diseases .
(2)
Section 404I of the Public Health Service Act ( 42 U.S.C. 283k ) is amended—
(A)
in subsection (a)(1), by striking  or the Director of the National Institute of Allergy and Infectious Diseases ; and
(B
by striking  or the National Institute of Allergy and Infectious Diseases  each place it appears.
(3)
Section 442A(a) of the Public Health Service Act ( 42 U.S.C. 285d–8(a) ) is amended by striking  Allergy and Infectious Diseases  and inserting  Immunologic Diseases .
(4)
Any reference in any law (including a regulation), guidance, map, document, record, or other paper of the United States to the National Institute of Allergy and Infectious Diseases, including with respect to the Director of such Institute, shall be deemed to be a reference to, as applicable, the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, or the National Institute of Immunologic Diseases, including with respect to the Directors of such Institutes.